AngioDynamics에 대한 매도 수량은 투자자에게 AngioDynamics의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

AngioDynamics (NASDAQ:ANGO) 주식, 공매도 수량 보고

AngioDynamics

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

ANGO

BIGC

LEVI

PCSA

목요일 아침 (현지 시간 기준) 미국 주식 선물이 하락세를 보이면서 오늘 투자자들의 관심을 끌 수 있는 주식은 다음과 같다: 1. 월스트리트는 컨스텔레이션 브랜드(NYSE:STZ)가 분기 이익을 주당 4.08달러, 매출 29억 달러로 발표할 것으로 예상하고 있다. 컨스텔레이션 주식은 애프터 마켓에서 0.3% 하락한 254.90달러로 거래되고 있다.

목요일 주목해야 할 주식: 컨스텔레이션 브랜드, 리바이 스트라우스 그리고 3종목

AngioDynamics Inc

ANGO WORLD HOLDINGS INC by ANGO World Holdings, Inc.

Angold Resources Ltd Ordinary Shares

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 0.2% on Thursday.
Following the market opening Thursday, the Dow traded up 0.16% to 17,954.10 while the NASDAQ gained 0.43% to 18,002.24. The S&amp;P 500 also fell, dropping, 0.03% to 5,707.82.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41161390/wall-streets-most-accurate-analysts-spotlight-on-3-defensive-stocks-delivering-high-divi">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Defensive Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Information technology shares jumped by 1.3% on Thursday.
In trading on Thursday, materials shares dipped by 0.9%.
Top Headline
The S&amp;P Global services PMI was revised lower to 55.2 in September compared to a preliminary reading of 55.4, and versus a reading of 55.7 in August.
The S&amp;P Global U.S. composite PMI sipped to 54 in September versus a preliminary reading of 54.4, and versus 54.6 in August.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Elevai Labs Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELAB#NASDAQ">ELAB</a>) shares shot up 67% to $0.1416 after the company announced its subsidiary, Elevai Biosciences, filed two patent applications for its lead candidate, EL-22, aimed at treating muscle loss in obese patients.</li>
<li>Shares of Theriva Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOVX#NASDAQ">TOVX</a>) got a boost, surging 47% to $1.8253 after the company announced the Data and Safety Monitoring Committee&#8217;s review outcome for its Phase 1b/2a clinical trial of SYN-004. The DSMC has recommended the study proceed to enroll cohort 3.</li>
<li>AMTD Digital Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HKD#NYSE">HKD</a>) shares were also up, gaining 39% to $0.1601.</li>
</ul>
Equities Trading DOWN
<ul>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares dropped 19% to $6.21 following first-quarter results.</li>
<li>Shares of Kaixin Holdings &nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) were down 11% to $0.3042. Shares of US-listed Chinese stocks traded lower as the sector pulled back from recent strength. These companies rallied after the People&#8217;s Bank of China announced a new stimulus package ahead of the Golden Week holidays.</li>
<li>Ingevity Corporation &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGVT#NYSE">NGVT</a>) was down, falling 14% to $32.22 as the company said John Fortson has departed as president and CEO and from the board of directors of the company, effective as of Oct. 2.</li>
</ul>
Commodities In commodity news, oil traded up 4.3% to $73.14 while gold traded down 0.1% at $2,667.50.
Silver traded up 0.3% to $32.015 on Thursday, while copper fell 2% to $4.5540.
Euro zone
European shares were mostly lower today. The eurozone's STOXX 600 fell 0.79%, Germany's DAX fell 0.69% and France's CAC 40 fell 0.97%. Spain's IBEX 35 Index rose 0.18%, while London's FTSE 100 fell 0.07%.
Producer prices in the Eurozone rose 0.6% month-over-month in August compared to a revised 0.7% increase in July. The HCOB Eurozone composite PMI was revised higher to 49.6 in September versus a preliminary reading of 48.9.
The S&amp;P Global UK services PMI declined to 52.4 in September from 53.7 in the previous month, while German services PMI fell to 50.6 in September from 51.2 a month ago.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 gaining 1.97%, Hong Kong's Hang Seng Index falling 1.47% and India's BSE Sensex dipping 2.10%.
The au Jibun Bank Japan services PMI was revised lower to 53.1 for September, versus a preliminary reading of 53.9.
Economics
<ul>
<li>U.S. initial jobless claims increased by 6,000 from the prior week to 225,000 during the week ended Sept. 28, compared to market estimates of 220,000.</li>
<li>The S&amp;P Global services PMI was revised lower to 55.2 in September compared to a preliminary reading of 55.4, and versus a reading of 55.7 in August.</li>
<li>The S&amp;P Global U.S. composite PMI sipped to 54 in September versus a preliminary reading of 54.4, and versus 54.6 in August.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41160677/top-3-consumer-stocks-which-could-rescue-your-portfolio-this-quarter">Top 3 Consumer Stocks Which Could Rescue Your Portfolio This Quarter</a></li>
</ul>

Equities

Eurozone

Commodities

Intraday Update

ELAB

KXIN

NGVT

TOVX

Crude Oil Jumps Over 4%; US Services PMI Revised Lower

WIIM

AngioDynamics shares are trading lower after the company reported worse-than-expected Q1 revenue results.

U.S. stocks were mostly lower, with the Dow Jones index falling around 300 points on Thursday.
Shares of AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) fell sharply during Thursday's session following <a href="https://www.benzinga.com/quote/ANGO/earnings">first-quarter results</a>.
AngioDynamics posted first-quarter adjusted loss of 11 cents per share, compared to market estimates of a loss of 15 cents per share. The company's quarterly sales came in at $67.491 million versus expectations of $67.933 million.
AngioDynamics shares dipped 15.6% to $6.45 on Thursday.
Here are some other big stocks recording losses in today's session.
<ul>
<li>Youdao, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAO#NYSE">DAO</a>) shares dipped 14.6% to $5.08.</li>
<li>Ingevity Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGVT#NYSE">NGVT</a>) shares declined 12.6% to $32.74 as the company said John Fortson has departed as president and CEO and from the board of directors of the company, effective as of Oct. 2.</li>
<li>Hims &amp; Hers Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NASDAQ">HIMS</a>) fell 11.1% to $16.85 in possible sympathy with Eli Lilly after the FDA announced their weight-loss drug shortage has ended.</li>
<li>Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) declined 9.1% to $19.14 after the company reported worse-than-expected third-quarter sales results and issued its FY24 adjusted EPS guidance with its midpoint below estimates. The company began a strategic review for its Dockers brand and is exploring a potential sale or other strategic transactions.</li>
<li>Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) dipped 8.8% to $5.59. Toyota announced plans to invest $500 million in Joby Aviation.</li>
<li>Bilibili Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BILI#NASDAQ">BILI</a>) shares fell 8.2% to $27.23. Shares of US-listed Chinese stocks traded lower as the sector pulled back from recent strength. These companies rallied after the People&#8217;s Bank of China announced a new stimulus package ahead of the Golden Week holidays.</li>
<li>Wolfspeed, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) dipped 7.5% to $8.45 after Mizuho downgraded the stock from Neutral to Underperform and cut its price target from $17 to $8.</li>
<li>GDS Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) fell 6.4% to $21.51.</li>
<li>Weibo Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WB#NASDAQ">WB</a>) dipped 5% to $10.65. Shares of US-listed Chinese stocks traded lower as the sector pulled back from recent strength.</li>
<li>Baidu, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) fell 4% to $110.49. Shares of US-listed Chinese stocks traded lower as the sector pulled back from recent strength.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41162047/top-2-tech-and-telecom-stocks-that-are-ticking-portfolio-bombs">Top 2 Tech And Telecom Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>

BIDU

BILI

Hims & Hers Health, Inc. Class A Common Stock

HIMS

JOBY

WOLF

AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday

Sentiment continues to be cautious as traders play the &#8220;wait-and-watch&#8221; game until they see off <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41148891/jobs-report-in-focus-will-slower-growth-push-the-fed-toward-november-interest-rate-">Friday&#8217;s non-farm payroll data.</a> The index futures traded moderately lower early Thursday. The weekly jobless claims data along with the ongoing tensions in the Middle East and the status of the dockworkers strike are among the key focal items for traders. The S&amp;P 500 has gained in all but one month so far this year and the momentum is supporting the market even as it navigates through another air pocket centered this time mainly around geopolitics.
Oil&#8217;s extended run could keep energy stocks buoyant and artificial intelligence stalwart Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) traded higher in premarket, while electric-vehicle stocks have decelerated.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Performance (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.44%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.33%</td>
</tr>
<tr>
<td>Dow</td>
<td>-0.36%</td>
</tr>
<tr>
<td>R2K</td>
<td>-0.67%</td>
</tr>
</tbody>
</table>
</figure>
In premarket trading on Thursday,&nbsp;the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) moved down 0.30% to $567.15 and the&nbsp;Invesco QQQ ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) slipped 0.39% to $480.09, according to&nbsp;<a href="https://benzinga.grsm.io/lxquj26b2sag" target="_blank" rel="noreferrer noopener">Benzinga Pro data</a>.
Cues From Last Session:
U.S. stocks closed Wednesday&#8217;s session marginally higher, as the market overcame early jitters set in motion by a stronger-than-expected private payrolls report and the ongoing headwinds such as the Middle East tensions and dockworkers&#8217; strike. After recouping early losses, the averages moved in a narrow range around the unchanged line before ending slightly higher.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>+0.08%</td>
<td>17,925.12</td>
</tr>
<tr>
<td>S&amp;P 500 Index</td>
<td>+0.01%</td>
<td>5,709.54</td>
</tr>
<tr>
<td>Dow Industrials</td>
<td>+0.09%</td>
<td>42,196.52</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.09%</td>
<td>2,195.01</td>
</tr>
</tbody>
</table>
</figure>
Seven of the 11 S&amp;P 500 sectors ended in the red, while energy stocks rallied strongly and IT stocks found moderate buying interest. Utility and financial stocks rose marginally.
Insights From Analysts:
The non-farm payrolls report due on Friday is expected to show job gains of 150,000 for September, up from 142,000 in August. JPMorgan Trading Desk <a href="https://x.com/TradingThomas3/status/1841607537445183928">predicts </a>a volatile Friday, with the S&amp;P 500 Index potentially moving either side of the flat line in a range of a 2% decline to a 1.5% gain depending on how the numbers pan out,
<ul>
<li>job gains over 20,000 &#8211; flat to 0.5% gain</li>
<li>160,000-20,000 &#8211; 1%-1.5% gain</li>
<li>140,000-160,000 &#8211; 0.75%-1.25%</li>
<li>110,000 &#8211; 140,000 &#8211; 0.5%-1.5% drop</li>
<li>less than 110,000 &#8211; 1.25%-2% drop</li>
</ul>
See also: <a href="https://www.benzinga.com/money/best-futures-trading-software">Best Futures Trading Software</a>
Upcoming Economic Data:
<ul>
<li>The Labor Department will release the weekly jobless claims data at 8:30 a.m. EDT. Economists, on average, expect the number of individuals claiming unemployment benefits to come in at 220,000 in the week ended Sept. 28, up from 218,000 in the previous reporting week.</li>
<li>S&amp;P Global is due to release its final service sector manufacturing index at 9:45 a.m. EDT. The flash reading released in mid-September came in at 55.4, up from 54.2 in August.</li>
<li>The Institute for Supply Management&#8217;s non-manufacturing PMI, due at 10 a.m. EDT, is expected at 51.7 in September, almost flattish at 51.5 reported for August.</li>
<li>The Commerce Department will release the factory goods orders report at 10 a.m. EDT. The consensus estimate calls for unchanged orders for August relative to September when orders climbed 5% month-over-month.</li>
<li>Minneapolis Fed President Neel Kashkari is due to moderate a discussion with Atlanta Fed President Raphael Bostic at 10:40 a.m. EDT.</li>
<li>The Treasury will auction four- and eight-week bills at 11:30 a.m. EDT.</li>
</ul>
Stocks In Focus:
<ul>
<li>Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) slumped nearly 11% <a href="https://www.benzinga.com/premarket">in premarket trading </a>on the company&#8217;s quarterly results released after the market close on Wednesday.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) and Constellation Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) are due to release their <a href="https://www.benzinga.com/calendars/earnings">quarterly results ahead of the market opening.</a></li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell over 1.50%, extending its slide from Wednesday, and most electric-vehicle stocks, including Rivian Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>), Lucid Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCID#NASDAQ">LCID</a>) and ChargePoint Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) all traded down about 2%.</li>
<li>Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) moved down 1.85% following a negative analyst action.</li>
</ul>
Commodities, Bonds And Global Equity Markets:
Crude oil futures continued their upward climb amid intensifying Middle East tensions, while gold futures fell modestly. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) declined over 1% below the $61K mark. The yield on the 10-year Treasury note rose 2.4 points to 3.809%.
Most Asian retreated barring the Japanese, Australian, New Zealand and Malaysian markers, while China and South Korea were closed for public holidays. The major European markets lost ground in early trading.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41159016/port-strike-enters-day-3-economist-warns-of-meaningful-impact-if-standoff-prolongs-food-beverages-li">Port Strike Enters Day 3: Economist Warns Of &#8216;Meaningful&#8217; Impact If Standoff Prolongs, Food &amp; Beverages Likely First To Feel The Pinch</a></li>
</ul>
Image Via Shutterstock

Futures

Previews

Economics

Federal Reserve

Movers

$BTC

CHPT

LCID

NVDA

PLUG

RIVN

TSLA

US Stocks Staring At Another Weak Open As Traders Await Key Jobs Report; Sentiment Wavers As Oil Extends Surge Amid Middle East Tensions

Guidance

Health Care

General

AngioDynamics Expects FY2025 Adjusted EPS Loss Of $(0.38)-$(0.42) Versus Consensus Of $(0.41)

For fiscal year 2025, the Company continues to expect:
<ul>
<li>Net sales to be in the range of $282 to $288 million, representing growth of between 4.2% &ndash; 6.4% over fiscal 2024 pro forma revenue of $270.7 million</li>
<li>Med Tech net sales are expected to grow in the range of 10% to 12%</li>
<li>Med Device net sales are expected to grow in the range of 1% to 3%</li>
<li>Gross margin to be approximately 52% to 53%</li>
<li>Adjusted EBITDA loss of $2.5 million to $0, compared to a pro forma adjusted EBITDA loss of $3.2 million in fiscal year 2024</li>
<li>Adjusted loss per share in the range of $0.38 to $0.42, compared to pro forma adjusted loss per share of $0.45 in fiscal year 2024</li>
</ul>

AngioDynamics Expects FY2025 Net Sales Of $282M-$288M Versus Consensus Of $284.367M

AngioDynamics Q1 2025 Adj. EPS $(0.11) Beats $(0.15) Estimate, Sales $67.491M Miss $67.933M Estimate

AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) will release earnings results for its first quarter, before the <a href="https://www.benzinga.com/quote/ANGO/earnings">opening bell on Thursday, Oct. 3.</a>
Analysts expect the Latham, New York-based company to report a quarterly loss at 15 cents per share, versus a year-ago loss of 12 cents per share. AngioDynamics is projected to post quarterly revenue of $67.93 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Sept. 3, AngioDynamics announced CE Mark approval for Auryon System in Europe.
AngioDynamics shares gained 0.3% to close at $7.65 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/ango/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5defa41dbffdfc00019394f4/yi-chen">HC Wainwright analyst Yi Chen</a> reiterated a Buy rating with a price target of $14 on Sept. 20. This analyst has an accuracy rate of 63%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58580533ee7bf60001bcfa0d/steven-lichtman">Oppenheimer analyst Steven Lichtman</a> upgraded the stock from Perform to Outperform with a price target of $12 on April 5. This analyst has an accuracy rate of 74%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58933b2143eaaa0001698f4f/jayson-bedford">Raymond James analyst Jayson Bedford</a> maintained an Outperform rating and cut the price target from $12 to $10 on Jan. 9. This analyst has an accuracy rate of 71%.</li>
</ul>
Considering buying ANGO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="526" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03033436/image-7-1024x526.png" alt="" class="wp-image-578034" style="width:592px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03033436/image-7-1024x526.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03033436/image-7-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03033436/image-7-768x395.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/03033436/image-7.png 1315w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41156151/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>

Price Target

Analyst Ratings

Top Wall Street Forecasters Revamp AngioDynamics Price Expectations Ahead Of Q1 Earnings

The CNN Money Fear and Greed index showed an improvement in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Wednesday.
U.S. stocks settled slightly higher on Wednesday, amid increasing tensions in the Middle East.
NIKE, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) <a href="https://www.benzinga.com/news/earnings/24/10/41147332/nike-stock-is-tumbling-wednesday-whats-going-on">shares fell</a> around 7% on Wednesday after multiple firms cut their respective price targets on the stock following a first-quarter revenue miss.
On the economic data front, private businesses in the U.S. added 143,000 workers to their payrolls during the month of September compared to a revised 103,000 gain in August and higher than market estimates of 124,000, the ADP said.
Most sectors on the S&amp;P 500 closed on a negative note, with consumer discretionary, consumer staples, and communication services stocks recording the biggest losses on Wednesday. However, energy and information technology stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed higher by around 40 points to 42,196.52 on Wednesday. The S&amp;P 500 rose 0.01% to 5,709.54, while the Nasdaq Composite gained 0.08% at 17,925.12 during Tuesday's session.
Investors are awaiting earnings results from Constellation Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>), and AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 68.4, the index remained in the &#8220;Greed&#8221; zone on Wednesday, versus a prior reading of 67.8.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41156151/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

S&P Settles Slightly Higher Despite Middle East Concerns: Fear Index Remains In 'Greed' Zone

With U.S. stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Constellation Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) to report quarterly earnings at $4.08 per share on revenue of $2.90 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Constellation shares fell 0.3% to $254.90 in after-hours trading.</li>
<li>Levi Strauss &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) <a href="https://www.benzinga.com/news/earnings/24/10/41151280/levi-strauss-co-stock-falls-after-mixed-q3-results-eps-beat-revenues-miss">posted</a> better-than-expected earnings for its third quarter, while sales missed estimates. The company said it sees fiscal year 2024 adjusted earnings at a mid-point of between $1.17 and $1.27 per share, versus the $1.25 estimate. Levi Strauss shares dipped 10.9% to $18.76 in the after-hours trading session.</li>
<li>Analysts expect AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) to post a loss at 15 cents per share on revenue of $67.93 million for the latest quarter. The company will release earnings before the markets open. AngioDynamics shares gained 2.1% to $7.81 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>BigCommerce Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIGC#NASDAQ">BIGC</a>) named Travis Hess as CEO. Brent Bellm will no longer serve as the company's CEO or as Chairman of the Board. BigCommerce shares gained 1.4% to $5.75 in the after-hours trading session.</li>
<li>Processa Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) shares surged in Wednesday's after-hours trading after the company announced the dosing of its first patient for the Phase 2 trial of NGC-Cap. Processa Pharmaceuticals shares gained 3% to $1.37 in the after-hours trading session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41156151/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yi">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo courtesy: Constellation Brands

Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday

HC Wainwright &amp; Co. analyst Yi Chen reiterates AngioDynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) with a Buy and maintains $14 price target.

Reiteration

HC Wainwright & Co. Reiterates Buy on AngioDynamics, Maintains $14 Price Target

Biotech

AngioDynamics Initiates RECOVER-AV Clinical Trial Of AlphaVac F18⁸⁵ System In Pulmonary Embolism And Long-Term Functional Outcomes

AngioDynamics Announces CE Mark Approval For Auryon System In Europe

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Monday.
Shares of PDD Holdings Inc &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/news/earnings/24/08/40548945/temu-parent-pdd-posts-86-q2-topline-growth-stock-drops-after-ceo-flags-upcoming-challenges">second-quarter revenue miss.</a>
PDD reported fiscal second-quarter 2024 revenue growth of 86% year-on-year to $13.36 billion (97.06 billion Chinese yuan), missing the analyst consensus estimate of $14.02 billion. The Chinese online retailer's adjusted earnings per ADS of $3.20 (23.24 Chinese yuan) increased from 10.47 Chinese yuan Y/Y, beating the analyst consensus estimate of $2.73.
PDD shares dipped 15.2% to $118.65 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>SM Energy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) fell 7.5% to $42.42 in pre-market trading after gaining over 3% on Friday.</li>
<li>Westlake Chemical Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) shares dipped 5.4% to $21.50 in pre-market trading.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares fell 5.1% to $7.29 in pre-market trading.</li>
<li>Daqo New Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) shares declined 5.1% to $14.43 in pre-market trading after reporting downbeat quarterly results.</li>
<li>Yiren Digital Ltd &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) shares fell 4.6% to $4.63 in pre-market trading.</li>
<li>elf Beauty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) shares declined 3.8% to $164.50 in pre-market trading.</li>
<li>Guardant Health Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) shares fell 3% to $28.20 in pre-market trading after gaining 4% on Friday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40547904/pvh-likely-to-report-higher-q2-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earn">PVH Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Citigourp Global Markets 2% Protected Notes Linked To The Djia

WLKP

PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Accuray Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aray#NASDAQ">ARAY</a>) and Halifax Health announced a breakthrough in cancer treatment at the Charles L. and Miki N. Grant Cancer Center for Hope in Port Orange, FL. The center&#39;s medical team became the first in the United States to treat cancer patients using Accuray&#39;s Radixact System with VitalHold technology. This innovative system is designed to enhance the precision of radiation therapy by improving patient positioning and monitoring throughout the treatment process, offering a new standard of care for a wide range of cancer cases, including breast cancer.
<h3>Significance of Radixact</h3>
Per Accuray, Radixact System, backed by VitalHold and other advanced technologies like ClearRT helical CT imaging and Synchrony real-time adaptive delivery, represents a significant advancement in radiotherapy. VitalHold&#39;s surface-guided radiotherapy (SGRT) ensures accurate patient positioning, improving the reproducibility of treatments and enabling deep inspiration breath hold techniques. This minimizes radiation exposure to critical organs, reducing long-term complications. The system&#39;s tattoo-free positioning further enhances patient experience, making radiation therapy more comfortable and cosmetically appealing.
The anticipated 35% increase in new cancer cases in the United States by 2040 underscores the critical need for advanced resources. Accuray&#39;s Radixact System, equipped with the VitalHold feature, is designed to meet this challenge by providing precise, high-quality radiation therapy from simulation through delivery. Management highlighted the partnership with Halifax Health, where the first U.S. patients have been treated using this innovative system, as a testament to its commitment.
<h3>Industry Prospects</h3>
Per a report in Precedence Research, the global radiation therapy market size is expected to be worth $7.47 billion in 2024. It is anticipated to reach $16.30 billion by 2033 at a CAGR of 8.6%.
The robust growth will be primarily driven by the increasing incidence of cancer, leading to higher demand for radiation therapy. Additionally, advancements in radiation therapy technology, including enhanced ionizing radiation and improved efficiency in targeting cancerous cells, are boosting its effectiveness and utilization in oncology.
Growing awareness about the benefits of advanced radiation therapy, along with initiatives to educate the public, is also accelerating market growth. The integration of innovative features and software systems in radiation therapy will enhance performance, driving increased demand and market value during the forecast period.
In June, Accuray announced that Heidelberg University Hospital in Germany is set to adopt its Radixact System, replacing its older TomoTherapy System.
<h3>Other Industry Players</h3>
Some other companies from the Medical Instruments industry making notable developments in their respective businesses are AngioDynamics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ango#NASDAQ">ANGO</a>), Intuitive Surgical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/isrg#NASDAQ">ISRG</a>) and Masimo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/masi#NASDAQ">MASI</a>). 
AngioDynamics is a pioneering medical technology company dedicated to advancing vascular health and cancer treatment.
In May, AngioDynamics received European CE Mark approval for its AlphaVac F1885 System, which is designed for the non-surgical removal of thrombi from pulmonary arteries and the treatment of pulmonary embolism.
Intuitive Surgical is a global leader in minimally invasive care and a pioneer of robotic surgery. Known for its da Vinci surgical system and Ion endoluminal system, Intuitive combines cutting-edge technology, advanced learning and supportive services to help healthcare providers deliver optimized patient care.
In June, Intuitive Surgical received FDA clearance for a labeling revision of its da Vinci X and Xi robotic systems specifically for radical prostatectomy. This update reflects real-world evidence showing that long-term survival rates for patients undergoing robotic-assisted radical prostatectomy are comparable to those receiving non-robotic procedures.
Masimo&#39;s a global medical technology company specializing in advanced monitoring technologies, including pulse oximetry, sensors, patient monitors and connectivity solutions. Known for its Masimo SET pulse oximetry, which has been proven to outperform other technologies in over 100 studies, Masimo&#39;s innovations have improved patient outcomes, particularly in neonates and post-surgical care.
This month, the Masimo W1 medical watch received FDA 510(k) clearance for connectivity with the Masimo SafetyNet telemonitoring solution. This integration allows the Masimo W1 watch, which provides continuous oxygen saturation and pulse rate measurements, to seamlessly transmit data to the Masimo SafetyNet app and clinician portal. This enables remote caregivers, including hospital clinicians, to monitor patient data from anywhere.
<a href="https://www.zacks.com/stock/news/2322538/accuray-s-aray-radixact-for-cancer-treatment-debuts-in-us?cid=CS-BENZ-FT-analyst_blog|company_news_medical_sector-2322538">To read this article on Zacks.com click here.</a>

Large Cap

Mid Cap

Penny Stocks

Small Cap

Management

ARAY

ISRG

MASI

Accuray's Radixact for Cancer Treatment Debuts in US

Canaccord Genuity analyst William Plovanic maintains AngioDynamics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) with a Buy and lowers the price target from $18 to $13.

Canaccord Genuity Maintains Buy on AngioDynamics, Lowers Price Target to $13

U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index surging more than 650 points on Tuesday.
The Dow traded up 1.63% to 40,865.59 while the NASDAQ fell 0.11% to 18,452.31. The S&amp;P 500 also rose, gaining, 0.37% to 5,652.28.
Check This Out: <a href="https://www.benzinga.com/news/24/07/39789748/wall-streets-most-accurate-analysts-weigh-in-on-3-industrials-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Industrials Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Industrials shares jumped by 2.3% on Tuesday.
In trading on Tuesday, information technology shares fell by 0.8%.
Top Headline
Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) reported better-than-expected second-quarter results.
Morgan Stanley reported second-quarter EPS of $1.82, up from $1.24 a year ago and beating the consensus of $1.65. The U.S. bank reported second-quarter sales of $15.02 billion, up 11.6% year over year, beating the consensus of $14.30 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares shot up 93% to $2.07 after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer&#8217;s drug.</li>
<li>Shares of Yoshitsu Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKLF#NASDAQ">TKLF</a>) got a boost, surging 92% to $0.5884 after the company reported a year-over-year increase in FY24 financial results.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares were also up, gaining 25% to $7.40 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) shares dropped 8% to $67.39 after Loop Capital downgraded the stock from Buy to Hold.</li>
<li>Shares of The Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) were down 9% to $68.55 following second-quarter results.</li>
<li>Clearmind Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) was down, falling 17% to $1.84. Clearmind Medicine announced the FDA clearance for IND application of MEAI-based CMND-100 oral capsule.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39789793/tecogen-and-3-other-stocks-under-5-insiders-are-buying">Tecogen And 3 Other Stocks Under $5 Insiders Are Buying</a>
Commodities In commodity news, oil traded down 1.3% to $80.82 while gold traded up 1.5% at $2,464.30.
Silver traded up 1.6% to $31.44 on Tuesday, while copper fell 1.7% to $4.4505.
Euro zone
European shares closed lower today. The eurozone's STOXX 600 fell 0.28%, Germany's DAX fell 0.39% and France's CAC 40 fell 0.69%. Spain's IBEX 35 Index fell 0.47%, while London's FTSE 100 fell 0.22%.
The ZEW Indicator of Economic Sentiment for the Eurozone fell by 7.6 points to a reading of 43.7 in July, while Eurozone posted a trade surplus of EUR 13.9 billion in May versus a year-ago gap of EUR 0.4 billion.
The ZEW Indicator of Economic Sentiment for Germany fell to 41.8 in July, recording the first decline in a year. Italy reported a trade surplus of EUR 6.43 billion in May versus a year-ago surplus of EUR 4.767 billion year.
Asia Pacific Markets
Asian markets closed mixed on Tuesday, with Japan's Nikkei 225 gaining 0.20%, Hong Kong's Hang Seng Index falling 1.60%, China's Shanghai Composite Index gaining 0.08% and India's S&amp;P BSE Sensex gaining 0.06%.
Economics
<ul>
<li>U.S. retail sales came in flat month-over-month for June compared to a revised 0.3% gain in the previous period.</li>
<li>Import prices came in unchanged from the prior month in June, while export prices in the U.S. declined 0.5% month-over-month in June.</li>
<li>The NAHB/Wells Fargo Housing Market Index fell by one point to a reading of 42 in July, versus market estimates of 44.</li>
<li>U.S. total business inventories increased by 0.5% month-over-month in May compared to a 0.3% gain in the earlier month.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39769294/top-5-financials-stocks-that-may-collapse-this-month">Top 5 Financials Stocks That May Collapse This Month</a></li>
</ul>

CMND

RDDT

SCHW

SILO

TKLF

Nasdaq Edges Lower; Morgan Stanley Earnings Top Views

Tuesday, AngioDynamics Inc&nbsp;(NASDAQ:&nbsp;ANGO) reported a fourth-quarter 2024 adjusted EPS loss of $0.05, compared to the consensus loss of $0.16.
Fourth-quarter sales totaled $70.98 million, beating the analyst consensus of $70.89 million, according to data from&nbsp;<a target="_blank" href="https://pro.benzinga.com/feature/newsfeed/?gspk=bHVrZWphY29iaTUzNDg&amp;gsxid=tdEE0VrK8Jeg&amp;ref=lukejacobi5348&amp;_gl=1&#x2A;1cdknur&#x2A;_ga&#x2A;Mjc5MjI1Mjg4LjE2OTcxMjgyNzY.&#x2A;_ga_V7ZK73W7N0&#x2A;MTY5ODk5Njg5OC4yNS4xLjE2OTg5OTcwMTAuMTcuMC4w" rel="noreferrer noopener">Benzinga Pro</a>.
Pro forma net sales rose 1.9% to $71.1 million. Med Tech segment net sales were $29.3 million, up 11.3% year over year.
Growth was driven by Auryon sales of $13.0 million, which increased 12.0%, NanoKnife disposable sales of $5.4 million, representing an increase of 18.0% compared to the fourth quarter of fiscal 2023, and AlphaVac sales of $1.9 million, an increase of <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39788500/angiodynamics-reports-fiscal-year-2024-fourth-quarter-and-full-year-financial-results" rel="noreferrer noopener">6.8% over the prior year</a>.
Med Device net sales were $41.8 million, a decrease of 3.8% compared to $43.4 million in the prior-year period.
AngioDynamics also announced a stock repurchase program of up to $15.0 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38045727/angiodynamics-resolves-decade-long-patent-litigation-with-becton-dickinson-in-settlement-agreeme" rel="noreferrer noopener">AngioDynamics Resolves Decade-Long Patent Litigation With Becton, Dickinson In Settlement Agreement</a>.
&#8220;We view 2025 as an inflection point in the trajectory of our business&#8230;The increased scale of our Med Tech business, in combination with the optimization of our Med Device business, will allow us to begin to see increasing leverage as we exit the year. Operationally, we will continue to work through the transition of our manufacturing model to reduce overhead costs and improve margins in 2026 and beyond,&#8221; commented Jim Clemmer, President and CEO.
Guidance: AngioDynamics expects its fiscal year 2025 net sales of $282 million-$288 million, up 4.2%–6.4% year over year from 2024 pro forma revenue of $270.7 million and <a href="https://www.benzinga.com/calendars/guidance">compared to the consensus of $287.68 million.</a>
The outlook includes Med Tech net sales to increase 10%-12%, and Med Device net sales are expected to grow 1%-3%.
Gross margin is expected to be approximately 52% to 53% for fiscal year 2025. Adjusted EBITDA loss of $2.5 million to $0, compared to a pro forma adjusted EBITDA loss of $3.2 million a year ago.
AngioDynamics forecasts fiscal year 2025 adjusted EPS loss of $0.38-$0.42, compared to fiscal 2024 pro forma adjusted EPS loss of $0.45 and consensus loss of $0.49.
Price Action: ANGO shares are up 25.6% at $7.445 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39793333/morgan-stanley-q2-earnings-higher-profits-as-investment-banking-activity-rebounds-on-track-to-reach" target="_blank" rel="noreferrer noopener">Morgan Stanley Q2 Earnings: Higher Profits As Investment Banking Activity Rebounds, On Track To Reach $10T Client Assets</a>.</li>
</ul>

Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance

Shares of The Charles Schwab Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) fell sharply during Tuesday's session following <a href="https://www.benzinga.com/quote/SCHW/earnings">second-quarter results.</a>
Charles Schwab said adjusted net income declined 2% Y/Y to $1.465 billion. Adjusted EPS fell 3% Y/Y to 73 cents, beating the consensus of 72 cents, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Charles Schwab shares dipped 7.5% to $69.42 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Yoshitsu Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKLF#NASDAQ">TKLF</a>) jumped 109% to $0.6437 after the company reported a year-over-year increase in FY24 financial results.</li>
<li>Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) shares climbed 95.4% to $2.12 after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer&#8217;s drug.</li>
<li>Logistic Properties of the Americas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPA#NYSE">LPA</a>) shares climbed 53.8% to $23.71.</li>
<li>NaaS Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) gained 38% to $3.8503.</li>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) gained 38% to $1.4799.</li>
<li>AEON Biopharma, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEON#NYSE">AEON</a>) shares rose 29.2% to $2.9450 after jumping around 63% on Monday.</li>
<li>Conduit Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDT#NASDAQ">CDT</a>) gained 27.3% to $0.3055 after declining over 8% on Monday.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) surged 24.7% to $7.39 after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance.</li>
<li>KWESST Micro Systems Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KWE#NASDAQ">KWE</a>) gained 22.8% to $0.4160</li>
<li>Zenvia Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENV#NASDAQ">ZENV</a>) climbed 22.7% to $1.9634. The company announced that it entered into an agreement with Alliance Global Partners to offer and sell Class A common shares up to $20 million.</li>
<li>Locafy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LCFY#NASDAQ">LCFY</a>) rose 21% to $4.4150.</li>
<li>SciSparc Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRC#NASDAQ">SPRC</a>) gained 20% to $1.0150.</li>
<li>Koss Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOSS#NASDAQ">KOSS</a>) rose 19.8% to $10.45.</li>
<li>Alpha Technology Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) climbed 19.2% to $3.42.</li>
<li>Meiwu Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) shares rose 16.1% to $1.01 after surging around 15% on Monday.</li>
<li>NetSol Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTWK#NASDAQ">NTWK</a>) climbed 16% to $3.0501 as the company signed a $16 million agreement with a major automaker to revolutionize digital car buying and leasing experience in the United States.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) gained 15% to $3.6440. Morgan Stanley analyst Josh Baer upgraded Chegg from Underweight to Equal-Weight and lowered the price target from $6.5 to $3.25.</li>
<li>8&#215;8, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) gained 13.3% to $2.8450. 8&#215;8. secured a $200 million term loan at reduced interest rate.</li>
<li>Fate Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FATE#NASDAQ">FATE</a>) gained 12.8% to $4.39.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PACB#NASDAQ">PACB</a>) rose 12.8% to $1.8350. PacBio is expected to hold its quarterly conference call to discuss its second quarter financial results on Wednesday, Aug. 7.</li>
<li>Newegg Commerce, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEGG#NASDAQ">NEGG</a>) gained 11.8% to $1.14.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) jumped 11.8% to $10.57</li>
<li>Sana Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) surged 11.7% to $7.11.</li>
<li>ServisFirst Bancshares, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFBS#NASDAQ">SFBS</a>) climbed 10.8% to $78.60 after the company reported better-than-expected second-quarter financial result. Also, Piper Sandler maintained a Neutral rating on the stock and raised its price target from $63 to $70.</li>
<li>Match Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) rose 7.9% to $34.54 after Starboard Value sent a letter to the company outlining initiatives for improving growth, profitability and capital allocation.</li>
<li>Arvinas, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) gained 7.7% to $32.27.</li>
<li>Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) shares rose 7.3% to $68.92 after B of A Securities upgraded the stock from Neutral to Buy.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Cyngn Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares fell 22.1% to $7.15 after jumping 54% on Monday.</li>
<li>Autonomix Medical, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMIX#NASDAQ">AMIX</a>) shares declined 21.4% to $1.08. Autonomix shares jumped 130% on Monday after the company entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Generator.</li>
<li>Zeo Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) fell 18% to $3.23.</li>
<li>Clearmind Medicine Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMND#NASDAQ">CMND</a>) fell 16.7% to $1.85. Clearmind Medicine announced the FDA clearance for IND application of MEAI-based CMND-100 oral capsule.</li>
<li>Crown LNG Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGBS#NASDAQ">CGBS</a>) declined 15.8% to $2.65.</li>
<li>Funko, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNKO#NASDAQ">FNKO</a>) shares fell 13.3% to $8.71.</li>
<li>Shapeways Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPW#NASDAQ">SHPW</a>) fell 13.2% to $0.3010.</li>
<li>Vicinity Motor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEV#NASDAQ">VEV</a>) shares dipped 12.8% to $0.5581 after dipping 10% on Monday.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) shares fell 8.7% to $37.04. Trump Media &amp; Technology Group shares jumped over 31% on Monday following the attempted assassination of Donald Trump.</li>
<li>Greenpro Capital Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRNQ#NASDAQ">GRNQ</a>) shares fell 8.5% to $1.08. Greenpro Capital shares surged around 35% on Monday after the company announced that its subsidiary, Green-X, secured over $100 million in digital assets.</li>
<li>Grom Social Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GROM#NASDAQ">GROM</a>) shares declined 7.8% to $0.3945 after gaining around 10% on Monday.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) fell 7.1% to $67.83 after Loop Capital downgraded the stock from Buy to Hold.</li>
<li>Eos Energy Enterprises, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EOSE#NASDAQ">EOSE</a>) fell 7% to $1.9150.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39792248/jim-cramer-says-if-you-sell-this-chinese-ev-stock-now-some-clown-will-be-real-posit">Jim Cramer Says If You Sell This Chinese EV Stock Now, &#8216;Some Clown&#8217; Will Be &#8216;Real Positive About It,&#8217; Wait Until &#8216;All That Stuff Happens</a><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39792248/jim-cramer-says-if-you-sell-this-chinese-ev-stock-now-some-clown-will-be-real-posit">&#8216;</a></li>
</ul>

AEON

AMIX

ARVN

ATGL

CGBS

CHGG

EGHT

EOSE

FATE

FNKO

GRNQ

GROM

KOSS

LCFY

MTCH

NAAS

NEGG

NTWK

PACB

SANA

SFBS

SHOP

SHPW

SPRC

VRPX

ZENV

Why Charles Schwab Shares Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

The key to successful investing lies in choosing the right stocks, though achieving this is no small feat. Investors employ a wide array of strateg...

TipRanks 'Perfect 10' List: 2 Top-Scoring Stocks Worth Watching

Earnings week ahead: Nike, Carnival, Constellation Brands, and more

This week, several major companies will be reporting earnings. Among them are Nike (NKE), Carnival (CCL), Constellation Brands (STZ), Conagra Brand...

Options Volatility and Implied Earnings Moves This Week, September 30 – October 04, 2024

AngioDynamics Q1 2025 Earnings Preview

Here's the major earnings before the open tomorrow

AngioDynamics Non-GAAP EPS of -$0.11 beats by $0.04, revenue of $67.5M misses by $0.42M

Today, several major companies are expected to report earnings: AngioDynamics (ANGO) and Constellation Brands (STZ). Ahead of earnings, TipRanks sh...

Options Volatility and Implied Earnings Moves Today, October 03, 2024

AngioDynamics ( ($ANGO) ) has shared an announcement. AngioDynamics announced a promising start to fiscal year 2025 with a slight increase in overa...

AngioDynamics Sees Growth Amidst Challenges in Fiscal 2025

AngioDynamics, Inc. 2025 Q1 - Results - Earnings Call Presentation

AngioDynamics, Inc. (ANGO) Q1 2025 Earnings Call Transcript

AIOT

AIXI

APOG

CALM

LFCR

MESA

MLEC

NEOV

PAYX

POCI

STBX

TRAK

UNFI

VLGEA

VRAR

WKEY

Press Releases

AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture

AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions

AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

AngioDynamics Reports Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results

AngioDynamics to Participate in Upcoming Investor Conferences

AngioDynamics Announces CE Mark Approval in Europe for the Auryon System

AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024

AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes

Comments

AngioDynamics

매도 수량

AngioDynamics (NASDAQ:ANGO) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌